Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Jelmyto

(jel-MY-toh)
A drug that contains the active ingredient mitomycin, which comes from the bacterium Streptomyces, and is used to treat adults with a certain type of urothelial cancer. It is given as a solution through a catheter that is placed into the ureter or kidney. Jelmyto damages the cell’s DNA and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of alkylating agent.
Search NCI's Dictionary of Cancer Terms